about
Overview of Nrf2 as Therapeutic Target in EpilepsyRelevance of the glutathione system in temporal lobe epilepsy: evidence in human and experimental modelsModulation of antioxidant enzymatic activities by certain antiepileptic drugs (valproic acid, oxcarbazepine, and topiramate): evidence in humans and experimental modelsMedicinal properties of mangosteen (Garcinia mangostana).Caenorhabditis elegans: A useful model for studying metabolic disorders in which oxidative stress is a contributing factor.Anticonvulsant and antioxidant effects of Tilia americana var. mexicana and flavonoids constituents in the pentylenetetrazole-induced seizuresAcetonic and Methanolic Extracts of Heterotheca inuloides, and Quercetin, Decrease CCl(4)-Oxidative Stress in Several Rat Tissues.Association of CYP8A1 (Prostacyclin I2 synthase) polymorphism rs5602 with breast cancer in Mexican woman.Status epilepticus: Using antioxidant agents as alternative therapies.Baclofen in the Therapeutic of Sequele of Traumatic Brain Injury: Spasticity.Biochemical and molecular modulation of CCl4-induced peripheral and central damage by Tilia americana var. mexicanaextractsThe effect of nordihydroguaiaretic acid on iodoacetate-induced toxicity in cultured neurons.Antioxidant activity of topiramate: an antiepileptic agent.Micronuclei in bone marrow and liver in relation to hepatic metabolism and antioxidant response due to coexposure to chloroform, dichloromethane, and toluene in the rat model.Association of Histopathological Markers with Clinico- Pathological Factors in Mexican Women with Breast Cancer.[Evaluation of the expression of p22 phox subunit of NADPH oxidase (NOX) in prostate cancer and benign prostatic hyperplasia: a comparative study]RNA expression of cytochrome P450 in Mexican women with breast cancer.Calcium-dependent production of reactive oxygen species is involved in neuronal damage induced during glycolysis inhibition in cultured hippocampal neurons.Pregnancy-associated plasma protein-A (PAPP-A) as a possible biomarker in patients with coronary artery disease.Differential Gene Expression Profile Induced by Valproic Acid (VPA) in Pediatric Epileptic PatientsEffects of Valproate Monotherapy on the Oxidant-Antioxidant Status in Mexican Epileptic Children: A Longitudinal StudyDD3(PCA3) gene expression in cancer and prostatic hyperplasiaNordihydroguaiaretic acid is a potent in vitro scavenger of peroxynitrite, singlet oxygen, hydroxyl radical, superoxide anion and hypochlorous acid and prevents in vivo ozone-induced tyrosine nitration in lungsHepatoprotective effect of acetonic and methanolic extracts of Heterotheca inuloides against CCl(4)-induced toxicity in ratsCYP2W1, CYP4F11 and CYP8A1 polymorphisms and interaction of CYP2W1 genotypes with risk factors in Mexican women with breast cancerMolecular Cloning and Exploration of the Biochemical and Functional Analysis of Recombinant Glucose-6-Phosphate Dehydrogenase from Gluconoacetobacter diazotrophicus PAL5Identification of the NADP+ Structural Binding Site and Coenzyme Effect on the Fused G6PD::6PGL Protein from Giardia lambliaDose-Dependent Behavioral and Antioxidant Effects of Quercetin and Methanolic and Acetonic Extracts from Heterotheca inuloides on Several Rat Tissues following Kainic Acid-Induced Status EpilepticusEffects of Single and Double Mutants in Human Glucose-6-Phosphate Dehydrogenase Variants Present in the Mexican Population: Biochemical and Structural Analysis
P50
Q26799344-6D3BE2EB-C1EF-4637-AD84-074B3F5BE6C2Q26830615-583AF5BC-DA58-4FC6-A6F8-4FCA460EA82FQ27010741-A95DE36F-B5C3-4087-9EC6-222EE4AD41E5Q33362993-5A61DF72-4681-49B5-9294-307FEFDFD8E0Q33736292-F179AB8F-90B4-4ADF-935F-62906BEA18C4Q34100674-74F62E09-5523-48F7-8102-718C75FCDE04Q36566139-3E4A85BD-D348-4BAF-8550-C70DF54E7888Q36878734-D7F48A05-3F44-4C7E-BC2B-075421CCE694Q37288222-666011C7-6099-42E8-BCE0-474A5FE0A566Q37409633-1350CDE1-AEF4-44AC-9138-7963BABF86E7Q37709819-6BF5554E-E8BD-45DB-BE74-AC13FF194654Q38958895-42D375A1-908F-4B73-B894-1E490E1BCB45Q39337872-C6F8F125-E41F-4AAA-A33D-B748734B321BQ40570185-4D8241A5-7EDC-4FAF-A545-1B884C1D807DQ40991107-50FB3AD3-6C91-469D-8AF8-CFD39073B05FQ43063111-DB447777-2CDB-4255-9A32-E894146A3185Q44059167-A5044477-BDF2-419F-B58D-941CDA17EB83Q46738920-A0C26306-BBB1-4248-89F9-B713A8C6BA3DQ51405047-6D09BD11-75EE-4985-927B-9DBC98D0C19AQ57583359-49BB9052-0FB6-4A4D-A600-457107BF4AF5Q60919999-F07A00FB-DFD0-495D-BBC5-86D802D5078BQ82214383-CDBB42EC-C8E2-48FB-9F25-32BA17D255DDQ82901635-1010FD94-7D07-4066-A58F-C8CF1F685F26Q83185754-4807623C-4298-47DB-B7B4-2D60A13F9C98Q84219883-0BE3B773-8B93-49E2-94D7-60A9CA2259F5Q90946462-E586F8CB-AEDC-4D4E-BCE9-4304B08D0012Q92354074-0F5446A0-A683-4A35-96D3-F300F96DD972Q92716149-65BDA6BD-9552-4965-957C-E18A9B225AADQ93189915-4FC1E710-3A48-49BC-A5B3-6498CE672302
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Noemí Cárdenas-Rodríguez
@en
Noemí Cárdenas-Rodríguez
@nl
type
label
Noemí Cárdenas-Rodríguez
@en
Noemí Cárdenas-Rodríguez
@nl
prefLabel
Noemí Cárdenas-Rodríguez
@en
Noemí Cárdenas-Rodríguez
@nl
P31
P496
0000-0002-6580-3440